Walgreens Stock Gets a Boost After Beating Earnings Estimates—But the Chain Still Needs a Prescription for Growth

Walgreens needs a strong prescription–for recovery. After Walgreens CEO Stefano Pessina called the second quarter “the most difficult” since the company’s acquisition of Alliance Boots in 2014, Walgreens Boots Alliance surprised Wall Street by beating third-quarter earnings, reporting adjusted earnings of $1.47 per share compared to Refinitiv expectations of $1.43. The drugstore chain’s stock shot […]